Cathelicidin anticorps

N° du produit ABIN965742

Détail du produit anti-Cathelicidin anticorps

Antigène: Cathelicidin (CAMP) (Cathelicidin Antimicrobial Peptide (CAMP))

Reactivité: Veuillez nous consulter SVP

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp Cathelicidin est non-conjugé

Application: ELISA

Purification: Ascitic fluid

Immunogène: cAMP, conjugated to KLH.

Clone: 9H4C4

Isotype: IgG1

Information d'application

Indications d'application: ELISA: Propose dilution 1/10000.
Not yet tested in other applications.
Determining optimal working dilutions by titration test.

Restrictions: For Research Use only

Stockage

Format: Liquid

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C

Références pour anticorps anti-Cathelicidin (ABIN965742)

J: "[SOFMER, its topicality and its prospects]." dans: Annales de réadaptation et de médecine physique : revue scientifique de la Société française de rééducation fonctionnelle de réadaptation et de médecine physique, Vol. 51, Issue 5, pp. 329-31, (2008) (PubMed).

Détails sur Cathelicidin

Antigène: Cathelicidin (CAMP) (Cathelicidin Antimicrobial Peptide (CAMP))

Autre désignation: cAMP (CAMP Produits)

Synonymes: anticorps CAP-18, anticorps CAP18, anticorps CRAMP, anticorps FALL-39, anticorps FALL39, anticorps LL37, anticorps CATH-2, anticorps Cnlp, anticorps Cramp, anticorps MCLP, anticorps CATH-B1, anticorps CATHB1, anticorps CATHL2, anticorps CATHL7, anticorps CAP11, anticorps cathelicidin antimicrobial peptide, anticorps CAMP, anticorps LOC100136187, anticorps LOC100136439, anticorps Camp

Classe de substances: Chemical

Sujet: Cyclic adenosine monophosphate (cAMP) plays a key role as an intracellular second messenger for transduction events that follow a number of extracellular signals. The G-Protein Coupled Receptors (GPCR) is the largest family of cell surface receptors. They can be activated by different ligands, such as neurotransmitters, hormones, ions, small molecules, peptides, and other physiological signaling molecules. Typically, the binding of the ligands to its receptor resulting in the activation of G-proteins, in return, activates the effector adenylyl cyclase evoking the production of cAMP. The activation of a protein kinase by cAMP results in the phosphorylation of substrate proteins. Currently successful drugs in marketing have been developed to target these receptors. Among the GPCRs, ~367 receptors are potential drug development targets, but only about 20 have been used to generate therapeutically and commercially successful drugs so far. Because the involvement of cAMP can amplify the response of the ligand binding, the second messenger cAMP has been largely employed to monitor the activation of the GPCR to facilitate the therapeutic drug discovery
Synonyms: cAMP

Pathways: Cellular Response to Molecule of Bacterial Origin